Renal involvement in Systemic Sclerosis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000062" target="_blank" >RIV/00023728:_____/19:N0000062 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11150/19:10406003 RIV/00179906:_____/19:10406003
Výsledek na webu
<a href="https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/renal-involvement-in-systemic-sclerosis" target="_blank" >https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/renal-involvement-in-systemic-sclerosis</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5772/intechopen.87187" target="_blank" >10.5772/intechopen.87187</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Renal involvement in Systemic Sclerosis
Popis výsledku v původním jazyce
Scleroderma renal crisis (SRC) is classical renal disease in systemic sclerosis (SSc). SRC is a relatively rare manifestation, approximately in 5% of patients. In terms of severity, manifestation in the form of SRC is the most common cause of acute organ failure. In SSc patients, SRC is defined as a new onset of accelerated arterial hypertension and rapidly progressive anuric or oliguric renal failure. SRC is primarily vascular injury with increased activity of the renin-angiotensin activity. These events lead to release or activation of cytokines and growth factors that result in the typical proliferative vascular lesions. Successful approach is routine use of angiotensin-converting enzyme inhibitors in the treatment of SRC (except prevention) and other advances in renal replacement therapy in SSc management. It is crucial to detect manifestations of SRC early and to manage appropriately in collaboration with intensive care medicine, cardiologists, and nephrologists. In contrast to SRC, clinical presentation of interstitial renal disease is poor, often without evidence of renal abnormality. Interestingly, other renal manifestations are glomerulonephritis and vasculitis. These manifestations are associated with overlapping mechanisms. The objective of this chapter is to focus on actual knowledge about the renal involvement in SSc and current treatment principles and possibilities.
Název v anglickém jazyce
Renal involvement in Systemic Sclerosis
Popis výsledku anglicky
Scleroderma renal crisis (SRC) is classical renal disease in systemic sclerosis (SSc). SRC is a relatively rare manifestation, approximately in 5% of patients. In terms of severity, manifestation in the form of SRC is the most common cause of acute organ failure. In SSc patients, SRC is defined as a new onset of accelerated arterial hypertension and rapidly progressive anuric or oliguric renal failure. SRC is primarily vascular injury with increased activity of the renin-angiotensin activity. These events lead to release or activation of cytokines and growth factors that result in the typical proliferative vascular lesions. Successful approach is routine use of angiotensin-converting enzyme inhibitors in the treatment of SRC (except prevention) and other advances in renal replacement therapy in SSc management. It is crucial to detect manifestations of SRC early and to manage appropriately in collaboration with intensive care medicine, cardiologists, and nephrologists. In contrast to SRC, clinical presentation of interstitial renal disease is poor, often without evidence of renal abnormality. Interestingly, other renal manifestations are glomerulonephritis and vasculitis. These manifestations are associated with overlapping mechanisms. The objective of this chapter is to focus on actual knowledge about the renal involvement in SSc and current treatment principles and possibilities.
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
—
OECD FORD obor
30226 - Rheumatology
Návaznosti výsledku
Projekt
<a href="/cs/project/NV16-33542A" target="_blank" >NV16-33542A: Role Hsp90 (Heat shock protein 90) u vybraných revmatických onemocnění</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
New Insight into Systemic Sclerosis
ISBN
978-1-83962-204-5
Počet stran výsledku
22
Strana od-do
41-62
Počet stran knihy
148
Název nakladatele
IntechOpen
Místo vydání
London
Kód UT WoS kapitoly
—